Hikal Q2 FY25 revenue stood at Rs. 453 Cr

In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%

Zydus Wellness Q2 FY25 sales up 12% at Rs. 490.7 Cr

Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore

Orchid Pharma Q2 FY25 PAT up 26% YoY driven by strategic initiatives for market expansion

Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr

Hospital business revenues increase 13.9% to Rs. 1,655 crore

DuPont launches Tyvek to support sustainable healthcare packaging

Tyvek with Renewable Attribution is designed to help reduce the carbon footprint

JB Pharma posts Q2 FY25 PAT 16% higher at Rs. 175 Cr

JB’s domestic business continued to out-perform the market with all our major brands posting strong growth

UPM, Selenis and Bormioli Pharma introduce the world's first pharmaceutical bottle partially made with wood-based plastics

The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency

Merck and Moderna initiate Phase 3 trial evaluating adjuvant V940 in combination with Keytruda

The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program

PM Modi launches and inaugurates Rs. 12,850 crore health projects at AIIA, New Delhi

These initiatives signify a substantial boost to healthcare infrastructure across India, aligned with the Prime Minister’s mission of ensuring quality healthcare services nationwide

AIIMS Delhi hosts workshop on ‘Emerging Technologies for Healthcare’

The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power